Related Experiment Video
Updated: Aug 12, 2026
13:04
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Treatment of hepatitis C
1University of Toronto, Ontario, Canada.
Journal of Viral Hepatitis
|April 27, 2005
Summary
Pegylated interferon alpha and ribavirin combination therapy offers over 50% sustained response in hepatitis C patients. Higher efficacy, exceeding 70%, is seen in genotypes 2 and 3.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) infection is a major global health concern.
- Previous treatments for HCV had limited efficacy.
- Combination therapy emerged as a promising strategy.
Purpose of the Study:
- To review the efficacy and application of pegylated interferon alpha and ribavirin combination therapy for hepatitis C.
- To identify contraindications and factors influencing treatment response.
- To outline management strategies for specific patient populations.
Main Methods:
- Review of existing literature on pegylated interferon alpha and ribavirin combination therapy.
- Analysis of sustained virologic response (SVR) rates across different patient groups and HCV genotypes.
- Examination of factors impacting treatment outcomes.
Main Results:
- Overall sustained response rates exceeded 50% with combination therapy.
- Sustained response rates surpassed 70% for patients with hepatitis C genotypes 2 and 3.
- Identified key factors influencing treatment success and contraindications.
Conclusions:
- Combination therapy with pegylated interferon alpha and ribavirin significantly improves hepatitis C treatment outcomes.
- Genotype-specific response rates highlight the importance of personalized treatment approaches.
- Understanding contraindications and influencing factors is crucial for optimizing patient care.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...